Establishes an emergency insulin program and trust fund to ensure access to analog insulins for those in need.
New York Senate Bill S01917 establishes an emergency insulin program and corresponding trust fund to facilitate emergency access to analog insulins. The program aims to ensure that individuals diagnosed with type one diabetes or type two insulin-dependent diabetes, who are at risk of serious adverse health effects due to a lack of insulin, can access necessary supplies. The bill also sets standards for analog insulin prescribing, dispensing, distribution, and possession, and allows for a sliding scale for cost-sharing for certain recipients.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.